Fundz

Who to call at Senti Biosciences, and when

Fundz watches for the moments Senti Biosciences starts buying, and tells you who to reach.

  • An alert the day Senti Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Senti Biosciences, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Senti Bio Awarded $8 Million Grant from California Institute for Regenerative Medicines for Clinical Development of Logic Gated CAR-NK Cell Therapy

Jul 01, 2024

Contract Type

partnership

South San FranciscoBiotechnology

Description

Senti Biosciences, Inc. (Nasdaq: SNTI) has announced that the California Institute for Regenerative Medicines has awarded an $8 million grant to support the ongoing clinical development of SENTI-202, a potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural killer (CAR-NK) investigational cell therapy for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia.

Company Information

Company

Senti Biosciences

Location

South San Francisco, California, United States

About

Senti Biosciences, Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform.

Related People

Faraz
Likely contact at this company
••••••••@••••••••

See Faraz's verified email →

Faraz
Senior decision-maker at this company
••••••••@••••••••

See Faraz's verified email →

Thomas
Senior decision-maker at this company
••••••••@••••••••

See Thomas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Senti Biosciences's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Senti Biosciences signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.